1357362-67-4

Basic information

• Product Name: 4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl 2-((4-(nitrooxy)butanoyl)oxy)benzoate
• Synonyms: 4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl 2-((4-(nitrooxy)butanoyl)oxy)benzoate
• CAS NO: 1357362-67-4
• Molecular Weight: 477.54
• Mol File: 1357362-67-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 671.5±65.0 °C(Predicted)
• Density: 1.53±0.1 g/cm3(Predicted)
• CAS DataBase Reference: 4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl 2-((4-(nitrooxy)butanoyl)oxy)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl 2-((4-(nitrooxy)butanoyl)oxy)benzoate(1357362-67-4)
• EPA Substance Registry System: 4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl 2-((4-(nitrooxy)butanoyl)oxy)benzoate(1357362-67-4)

Safety Data

• Hazardous Substances Data: 1357362-67-4(Hazardous Substances Data)

Upstream product

• 90-02-8 salicylaldehyde 
• 18274-81-2 desmethyl anethole trithione 
• 937808-67-8 2-formylphenyl 4-bromobutanoate 

Relevant articles and documents

NO- AND H2S- RELEASING COMPOUNDS

This disclosure relates to novel compounds containing an H2S releasing moiety and a nitric oxide (NO) releasing moiety covalently linked with a core (e.g., a salicylic acid moiety) and the use of such compounds in treating inflammatory diseases, including

NOSH-aspirin: A novel nitric oxide-hydrogen sulfide-releasing hybrid: A new class of anti-inflammatory pharmaceuticals

A series of new hybrids of aspirin (ASA), bearing both nitric oxide (NO) and hydrogen sulfide (H2S)-releasing moieties were synthesized and designated as NOSH compounds (1-4). NOSH-1 (4-(3-thioxo-3H-1,2-dithiol-5-yl) phenyl 2-((4-(nitrooxy)buta